Invasive serous and undifferentiated ovarian carcinomas are characterized by TP53 mutations and TP53 protein accumulation. Loss of genetic material from chromosome 17 is also common.
Overexpression of BCL2 is seen in most endometrioid carcinomas (90% of cases). These tumours can also show microsatellite instability
KRAS mutations are characteristic for mucinous carcinomas (40-50% of cases). In
mucinous tumors with low malignant potential (LMP) KRAS mutations are less frequent ( about 30% of cases).